SB
PFE icon

SIG Brokerage’s Pfizer PFE Stock Holding History

SIG Brokerage’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.38M Buy
140,400
+20,000
+17% +$523K 0.07% 235
2026
Q1 		$3.38M Buy
120,400
+80,400
+201% +$2.14M 0.09% 184
2025
Q4 		$996K Buy
40,000
+10,000
+33% +$252K 0.03% 364
2025
Q3 		$764K Buy
30,000
+18,600
+163% +$459K 0.02% 444
2025
Q2 		$276K Buy
+11,400
New +$266K 0.01% 572

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

SIG Brokerage's PFE Position: Q2 2026 in Review

SIG Brokerage increased its Pfizer (PFE) stake by 70% in Q2 2026, buying an estimated $558K and bringing the position to 52,022 shares worth $1.25M. The position accounts for 0.02% of the portfolio, ranked #423.

SIG Brokerage first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $2.42M in Q1 2025. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • SIG Brokerage held 52,022 shares of Pfizer worth $1.25M as of Q2 2026.
  • SIG Brokerage bought 21,336 Pfizer shares in Q2 2026, an estimated $558K.
  • Pfizer made up 0.02% of SIG Brokerage's portfolio in Q2 2026, its #423 holding.
  • SIG Brokerage first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • SIG Brokerage's Pfizer position peaked at $2.42M in Q1 2025.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on SIG Brokerage's 13F filing for Q2 2026, filed 14 Aug 2026.